Whanin Pharmaceutical Co. Ltd. | Ownership
Companies that own Whanin Pharmaceutical Co. Ltd.
Shinyoung Asset Management Co., Ltd.
1,913,460
10.29%
-26,534
1.08%
04/04/2018
Fidelity Management & Research Co.
1,756,410
9.44%
39
0%
07/31/2018
National Pension Service of Korea
1,168,440
6.28%
416,871
0.02%
11/21/2017
International Value Advisers LLC
1,161,012
6.24%
344,816
0.24%
12/31/2017
Korea Investment Value Asset Management Co., Ltd.
1,140,214
6.13%
209,553
1.78%
12/31/2016
BlackRock Advisors (UK) Ltd.
292,144
1.57%
619
0%
09/06/2018
Dimensional Fund Advisors LP
246,970
1.33%
2,437
0%
04/30/2018
FIL Investment Management (Singapore) Ltd.
158,620
0.85%
16,138
0.04%
05/31/2018
TIAA-CREF Investment Management LLC
143,391
0.77%
0
0%
03/31/2018
Norges Bank Investment Management
78,240
0.42%
-15,609
0%
12/31/2017
| Address |
Whanin Building
Seoul SL 05809
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.whanin.com |
| Updated |
07/08/2019 |
| Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Lee Kwang-Sik in June 1978 is headquartered in Seoul, South Korea. |
